Opko Health And Teva Pharmaceutical Industries Surge Following Director's Resignation
Dr. Phillip Frost resigned from the Teva Pharmaceutical Industries Board of Directors, effective February 4, 2015. Professor Yitzhak Peterburg assumed the role of Chairman on January 1, a position previously held by Frost.
In a press release, Professor Yitzhak Peterburg said that “Dr. Frost has made significant contributions to Teva since joining the Board in 2006 with Teva’s acquisition of Ivax. He has been deeply influential in Teva’s growth and we have benefitted greatly from his experience and knowledge. We wish him continued success in his distinguished career.”
Dr. Frost currently holds the position of chairman and CEO at Opko Health.
Opko Health recently traded at $13.17, up 3.13 percent.
Teva Pharmaceutical recently traded at $57.96, up 2.6 percent.
© 2016 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.